Latest filing published 13 Jan 2026 for LISATA THERAPEUTICS, INC., €2,367.
Insider track record
Tariq Imam: trading record in brief
Tariq Imam discloses dealings in Lisata Therapeutics, Inc. to SEC (Form 4). Altogether 5 filings, all relating to 9 January 2026.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
On 13 January 2026 came the latest disclosure, a share grant for €2,367 in Lisata Therapeutics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. US insiders must file a Form 4 within two business days of a trade. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Tariq Imam
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,401 shares@ US$1.9740.0% of flowCommon StockSEC:0002055011-26-000003:1
- 840 shares@ US$1.9724.0% of flowCommon StockSEC:0002055011-26-000003:2
- 747 shares@ US$1.9721.3% of flowCommon StockSEC:0002055011-26-000003:3
- 513 shares@ US$1.9714.7% of flowCommon StockSEC:0002055011-26-000003:4
- 15,000 shares0Common StockSEC:0002055011-26-000003:0
5 of 5 declarations
